注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Biomerica Inc是一家生物医学技术公司,开发、专利、制造和销售先进的诊断和治疗产品。该公司的产品用于家庭护理点、医生办公室和医院/临床实验室,用于检测和治疗医疗条件和疾病。该公司还从事专利诊断引导治疗(DGT)产品的研究、开发、商业化以及某些情况下的监管批准,以治疗胃肠道疾病,如肠易激综合征(IBS)和其他炎症疾病。该公司的诊断测试试剂盒用于分析患者的血液、尿液、鼻腔或粪便样本,以诊断各种疾病、食物不耐症和其他医疗并发症。该公司的医疗诊断产品主要在两个市场销售:临床实验室和医疗点。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Allen C. Barbieri | 65 | 1999 | Executive Vice-Chairman of the Board & Corporate Secretary |
Edward W. Barnholt | 79 | 2016 | Chairman of Strategic Advisory Board |
Catherine Coste | 57 | 2020 | Independent Director |
Brooks Cash | - | 2021 | Chairman of Colorectal Screening Scientific Advisory Board |
David Moatazedi | 45 | 2022 | Independent Director |
Jane F. Emerson | 70 | 2007 | Independent Director |
Douglas A. Drossman | - | - | Member of the Scientific Advisory Board |
Harry L. Leider | 65 | 2018 | Member of Strategic Advisory Board |
Anthony J. Lembo | - | 2016 | Member of Scientific Advisory Board |
William D. Chey | - | - | Member of the Scientific Advisory Board |
Lin Chang | - | - | Member of the Scientific Advisory Board |
William Whitehead | - | - | Member of the Scientific Advisory Board |
John Patrick Kenny | 55 | 2023 | Independent Chairman of the Board |
Brian E. Lacy | - | 2023 | Member of Scientific Advisory Board |
Gary M. Huff | 57 | 2024 | Member of Strategic Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核